Fast Grants

Homeworld Collective Launches To Unite and Enable Climate Biotechnology Community

Retrieved on: 
Thursday, September 21, 2023

BOSTON, Sept. 21, 2023 /PRNewswire-PRWeb/ -- Homeworld Collective, the 501(c)(3) nonprofit igniting the growth of climate biotechnology, today introduced their nonprofit as the go-to source for scientists, technologists, entrepreneurs, and funders committed to maximizing the impact of climate biotechnology for planetary health. The launch also coincides with the announcement of their grantmaking system for building the field of climate biotech, Homeworld Garden Grants. In its first cycle, Homeworld Collective will deploy $1M in funding for climate biotech. The organization's goal is to foster a cohesive community across academia, industry, and funders in climate biotech that is organized around clear pathways to impact and develop viable solutions for problems plaguing our planet.

Key Points: 
  • Daniel Goodwin, Ph.D., and Paul Reginato, Ph.D., founders of Homeworld Collective, began building their global community in 2019 after recognizing the dire lack of community, resources, funding, and education in the field of climate biotechnology.
  • Having started as an informal community, Homeworld Collective was officially established as a nonprofit in 2022.
  • "We are empowering an attitude of action-oriented climate optimism," said Paul Reginato, Founding Co-Director of Homeworld Collective.
  • In contrast, climate biotechnology currently lacks the social infrastructure and problem maps that can enable people to connect to impactful work.

The Arc Institute Launches to Accelerate Scientific Breakthroughs in Complex Diseases in Collaboration with Stanford University, UCSF, and UC Berkeley

Retrieved on: 
Wednesday, December 15, 2021

By bringing together scientists across many disciplines, Arc aims to enable new discoveries that ultimately improve human health.

Key Points: 
  • By bringing together scientists across many disciplines, Arc aims to enable new discoveries that ultimately improve human health.
  • Were delighted to be part of the Arc Institute collaboration.
  • To unlock their full potential, we are structuring the Institute around four core concepts built to enable high-risk, high-reward science.
  • Arc investigators may hold faculty positions at Stanford, UC Berkeley, and UCSF, and graduate students enrolled at these universities will be able to pursue their PhD studies at Arc labs.

Robert Downey Jr.'s FootPrint Coalition Funds Fast Grants for New Environmental Science + Tech Fields

Retrieved on: 
Friday, December 17, 2021

This is about removing red tape and creating support systems for them," says Robert Downey Jr.

Key Points: 
  • This is about removing red tape and creating support systems for them," says Robert Downey Jr.
  • The program works differently from traditional science funding mechanisms, which normally allocate funding through review panels and lengthy application processes.
  • "The Fast Grants response to COVID-19 proved that science funding could move much faster.
  • FootPrint Coalition ( https://www.footprintcoalition.com ) is a business and nonprofit solely focused on the development, adoption and scaling of sustainable technologies.

Immune Response to COVID-19 Vaccine Different with Prior Infection

Retrieved on: 
Tuesday, October 12, 2021

Antibodies produced by the immune system's B cells can quickly recognize a virus, target it for destruction, and prevent infection.

Key Points: 
  • Antibodies produced by the immune system's B cells can quickly recognize a virus, target it for destruction, and prevent infection.
  • While antibodies are more effective at stopping initial infection completely, T cells generally last longer after an initial infection or vaccine and can help quell disease in its early stages, preventing severe symptoms.
  • Distinct subsets of T cells respond differently to infected cells and have different functions within the overall T cell response.
  • However, in those who had previously had a COVID-19 infection, there was little change between the first and second dose of the vaccine.